Rankings
▼
Calendar
FATE FY 2022 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$158M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$96M
+72.4% YoY
Gross Profit
$83M
85.7% margin
Operating Income
-$308M
-320.2% margin
Net Income
-$282M
-292.5% margin
EPS (Diluted)
$-2.91
Cash Flow
Operating Cash Flow
-$248M
Free Cash Flow
-$284M
Stock-Based Comp.
$79M
Balance Sheet
Total Assets
$706M
Total Liabilities
$222M
Stockholders' Equity
$484M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$96M
$56M
+72.4%
Gross Profit
$83M
$50M
+65.1%
Operating Income
-$308M
-$217M
-42.1%
Net Income
-$282M
-$212M
-32.8%
← Q4 2021
All Quarters
Q1 2022 →